Member Info for BurtonS

Fook off harvey

It'll be even better when the SP makes some progress.

I think that hydrogen is important to "heavy" transport such as trains and marine (particularly marine), I am not so sure when it comes to trucks and buses, especially since there is no infrastructure for road traffic. I seems to make sense, but maybe fuel cells will not get past range extending when it comes to road traffic, until there is an infrastructure in place.

I doff my hat to all you holders that have been here long enough to have a low average.
Mine is in the twenties, and I'm more than happy.
I wish I'd bought more today, because its going to be more expensive tomz!
Tonights presentation was fantastic. Aim market porn.

I have phoned HL to try and find the level of scale back on the restricted shares.

No exact figure was given, but it was suggested that I work on about 6.5% of those that I applied for.

Londonwolfie is right, and the raise is at something like 1060, then I think it is a great result.
Unfortunately I have primarybid on my laptop, and not the app, plus my bank balance would'nt be much help, so I didn't even consider applying for shares.
I'm just waiting to see the raise price and hoping that Londonwolfie is close to the mark.

Fook me
I can't understand the offer, it looks like there has been no price announced but the main players are fairly well committed (Bosch and Weichai) to it.
At first glance it looks like a major move into hydrogen production with 2024 being the year it all happens.

I guess that its massively positive, but I'm happy to be corrected. Why would someone with over £100m in the bank want shed loads more if it wasn't for a major opportunity???

I'm sure he said that 1 of the spin outs would be on the American markets.

The company currently has a lot of shares in issue...669m.
I wonder if CF is considering a share consolidation? A 1 for 5 would result in 133m shares, and on a pro rata basis, a share price of 150p approx. Stangely this would give a $ price just over $2, which might be better for a USA listing.
A smaller share issue would probably cause greater volatility though.
If CK could time a consolidation with someone buying the last of Invesco out, it could get very interesting.

Its worth having a look at EKF to get an Idea of how a spin out might work.
They announced an in specie issue of approx 1 share for every 20 held on the register at the close of play the previous day ( if my memory is correct) when they announced that they would be taking Trellus to an IPO. I'm a holder of EKF and now my "potential" Trellus shares are shown in my HL account. An IPO hasnt happened yet. So assuming there is an IPo I'll get them at whatever the launch price is, but at no cost to me. ( thats how I understand it)
I'm not ramping or promoting EKF, but I hope that this might help peeps to understand what ORPH may do. If the in specie issue is 1 for 1 I'll be gobsmacked, but also chuffed to bits!!

I missed the beginning, and the end due to family issues, so I watched/listened to about 20 mins.
But b*gger me, how positive was that?

Got off my lazy arse, I think it was approx 1 for 22.
With a launch price somewhere just above £1.
Please correct me if i've got it wrong

Can one of the long term holders tell me how the Renalytix launch went?
I'm hoping to get a feel for how many shares we are likely to get, relative to our shareholdings in EKF, should the shareholder vote be in positive.
I realise that ratio's will be involved and I'm wondering how it was done in the past.
I understand that the past is no guide to the future.

It's a funny pond that we're swimming in. I've read that Source Bioscience are going to announce a float on AIM this week.
They have placed a reasonable order recently with EKF, who just happen to be working with Ygen when it comes to testing students in Leicester.
Listen to the last webinar from EKF, and when the question was asked..."why don't you start doing your own testing?"...the answer was something like...it would cost too much and take too long, we leave that to company's like Yourgene.
Strange world, I think there is an awful lot going on beneath the surface.

Don't all shout, I've been here well over a year, nearer 2 i think without checking.
what do people think the margin will be for the company when it comes to covid testing. If some private individual pays, lets say £120 for a test..then how much does the outfit drawing the blood take?....how much does the courier get?.....how much does the lab cost to run the test? etc etc etc There are a shed load of costs involved.
What I'm trying to say, is that 10,000 tests in a month multiplied by say £120, does not drop onto the bottom line.
Whilst I'm excited about the testing, I'm trying to keep my feet on the ground.

I've just listened to the presentation again. At about 14min45sec in, when Colin is talking about the RTC, his voice changes.

I wonder if he switches to a prepared/approved statement by all the member companies. It's as if he's reading something.

Its working now

I've got the same

Interesting that the "industrial" customer has warehousing, (hope I heard that right) and is likely to start using EKF in Europe.
Amazon?? I can only dream!

TW is a w**nker who pumps and dumps, and fleeces PI's